REGENERON Trademark

Trademark Overview


On Friday, April 13, 2012, a trademark application was filed for REGENERON with the United States Patent and Trademark Office. The USPTO has given the REGENERON trademark a serial number of 85596884. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, March 20, 2023. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The REGENERON trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the treatment of ophthalmic diseases and conditions, and for the treatment of inflammation and inflammatory diseases and disorders

Providing medical information and treatment support programs in the nature of medical information via the telephone and the internet for professionals, patients, consumers, and the general public regarding pharmaceutical products and services

Research and development of pharmaceutical preparations; Genetic engineering services utilizing a collection of genetic technologies for the rapid production of human antibodies; Genetic engineering services, namely, deletion and modification of genes for others, and production of genetically modified animals; Genetic research; Genetic engineering services for genes, cells, and animals using non-human embryonic stem cells (ES) and non-human embryo manipulation technology for rapid development of genetically modified non-human animals
regeneron

General Information


Serial Number85596884
Word MarkREGENERON
Filing DateFriday, April 13, 2012
Status800 - REGISTERED AND RENEWED
Status DateMonday, March 20, 2023
Registration Number4225793
Registration DateTuesday, October 16, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 31, 2012

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of ophthalmic diseases and conditions, and for the treatment of inflammation and inflammatory diseases and disorders
Goods and ServicesProviding medical information and treatment support programs in the nature of medical information via the telephone and the internet for professionals, patients, consumers, and the general public regarding pharmaceutical products and services
Goods and ServicesResearch and development of pharmaceutical preparations; Genetic engineering services utilizing a collection of genetic technologies for the rapid production of human antibodies; Genetic engineering services, namely, deletion and modification of genes for others, and production of genetically modified animals; Genetic research; Genetic engineering services for genes, cells, and animals using non-human embryonic stem cells (ES) and non-human embryo manipulation technology for rapid development of genetically modified non-human animals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 19, 2012
Primary Code005
First Use Anywhere DateFriday, February 29, 2008
First Use In Commerce DateFriday, February 29, 2008

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 19, 2012
Primary Code042
First Use Anywhere DateFriday, April 15, 1988
First Use In Commerce DateFriday, April 15, 1988

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 19, 2012
Primary Code044
First Use Anywhere DateWednesday, November 30, 2011
First Use In Commerce DateWednesday, November 30, 2011

Trademark Owner History


Party NameRegeneron Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events


Event DateEvent Description
Monday, March 20, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, March 20, 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, March 20, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, March 20, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, September 2, 2022TEAS SECTION 8 & 9 RECEIVED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, October 16, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, October 24, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, October 24, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, October 24, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, October 9, 2018TEAS SECTION 8 & 15 RECEIVED
Monday, October 16, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 6, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 6, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 16, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, July 31, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 31, 2012PUBLISHED FOR OPPOSITION
Wednesday, July 11, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 25, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, June 21, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 20, 2012EXAMINER'S AMENDMENT ENTERED
Wednesday, June 20, 2012ASSIGNED TO LIE
Wednesday, June 20, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 20, 2012EXAMINERS AMENDMENT E-MAILED
Wednesday, June 20, 2012EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 19, 2012ASSIGNED TO EXAMINER
Thursday, April 19, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 17, 2012NEW APPLICATION ENTERED